 | • レポートコード：B-GIR09D3905 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、デガレリックスの世界市場について調べ、まとめました。種類別セグメントは、バイアルあたり120 mg、バイアルあたり80 mg等、用途別セグメントは、病院、ドラッグストア等に区分しました。デガレリックスの世界市場概観、企業動向、企業別デガレリックスシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・デガレリックスの市場概観 ・デガレリックスの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・デガレリックスの企業別販売動向、市場シェア、市場集中度、競争動向 ・デガレリックスの世界市場規模 ・デガレリックスの北米市場分析（アメリカ、カナダ、メキシコ等） ・デガレリックスのアメリカ市場規模推移 ・デガレリックスのカナダ市場規模推移 ・デガレリックスのメキシコ市場規模推移 ・デガレリックスのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・デガレリックスのドイツ市場規模推移 ・デガレリックスのイギリス市場規模推移 ・デガレリックスのロシア市場規模推移 ・デガレリックスのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・デガレリックスの日本市場規模推移 ・デガレリックスの中国市場規模推移 ・デガレリックスの韓国市場規模推移 ・デガレリックスのインド市場規模推移 ・デガレリックスの東南アジア市場規模推移 ・デガレリックスの南米市場分析（ブラジル、アルゼンチン等） ・デガレリックスの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・デガレリックスの種類別分析/販売量、売上、市場シェア（バイアルあたり120 mg、バイアルあたり80 mg） ・デガレリックスの用途別分析/市場規模（病院、ドラッグストア） ・デガレリックスの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・デガレリックスの販売チャネル・代理店・貿易業者・ディーラー分析 |
Degarelix (INN) or degarelix acetate (USAN), sold under the brand name Firmagon among others, is a hormonal therapy used in the treatment of prostate cancer.
Scope of the Report:
The global Degarelix market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Degarelix.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Degarelix market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Degarelix market by product type and applications/end industries.
Market Segment by Companies, this report covers
Ferring
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
120 mg per vial
80 mg per vial
Market Segment by Applications, can be divided into
Hospital
Drug store
Table of Contents
1 Degarelix Market Overview
1.1 Product Overview and Scope of Degarelix
1.2 Classification of Degarelix by Types
1.2.1 Global Degarelix Revenue Comparison by Types (2019-2024)
1.2.2 Global Degarelix Revenue Market Share by Types in 2018
1.2.3 120 mg per vial
1.2.4 80 mg per vial
1.3 Global Degarelix Market by Application
1.3.1 Global Degarelix Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Degarelix Market by Regions
1.4.1 Global Degarelix Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Degarelix Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Degarelix Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Degarelix Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Degarelix Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Degarelix Status and Prospect (2014-2024)
1.5 Global Market Size of Degarelix (2014-2024)
2 Manufacturers Profiles
2.1 Ferring
2.1.1 Business Overview
2.1.2 Degarelix Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Ferring Degarelix Revenue, Gross Margin and Market Share (2017-2018)
3 Global Degarelix Market Competition, by Players
3.1 Global Degarelix Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Degarelix Players Market Share
3.2.2 Top 10 Degarelix Players Market Share
3.3 Market Competition Trend
4 Global Degarelix Market Size by Regions
4.1 Global Degarelix Revenue and Market Share by Regions
4.2 North America Degarelix Revenue and Growth Rate (2014-2019)
4.3 Europe Degarelix Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Degarelix Revenue and Growth Rate (2014-2019)
4.5 South America Degarelix Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Degarelix Revenue and Growth Rate (2014-2019)
5 North America Degarelix Revenue by Countries
5.1 North America Degarelix Revenue by Countries (2014-2019)
5.2 USA Degarelix Revenue and Growth Rate (2014-2019)
5.3 Canada Degarelix Revenue and Growth Rate (2014-2019)
5.4 Mexico Degarelix Revenue and Growth Rate (2014-2019)
6 Europe Degarelix Revenue by Countries
6.1 Europe Degarelix Revenue by Countries (2014-2019)
6.2 Germany Degarelix Revenue and Growth Rate (2014-2019)
6.3 UK Degarelix Revenue and Growth Rate (2014-2019)
6.4 France Degarelix Revenue and Growth Rate (2014-2019)
6.5 Russia Degarelix Revenue and Growth Rate (2014-2019)
6.6 Italy Degarelix Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Degarelix Revenue by Countries
7.1 Asia-Pacific Degarelix Revenue by Countries (2014-2019)
7.2 China Degarelix Revenue and Growth Rate (2014-2019)
7.3 Japan Degarelix Revenue and Growth Rate (2014-2019)
7.4 Korea Degarelix Revenue and Growth Rate (2014-2019)
7.5 India Degarelix Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Degarelix Revenue and Growth Rate (2014-2019)
8 South America Degarelix Revenue by Countries
8.1 South America Degarelix Revenue by Countries (2014-2019)
8.2 Brazil Degarelix Revenue and Growth Rate (2014-2019)
8.3 Argentina Degarelix Revenue and Growth Rate (2014-2019)
8.4 Colombia Degarelix Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Degarelix by Countries
9.1 Middle East and Africa Degarelix Revenue by Countries (2014-2019)
9.2 Saudi Arabia Degarelix Revenue and Growth Rate (2014-2019)
9.3 UAE Degarelix Revenue and Growth Rate (2014-2019)
9.4 Egypt Degarelix Revenue and Growth Rate (2014-2019)
9.5 Nigeria Degarelix Revenue and Growth Rate (2014-2019)
9.6 South Africa Degarelix Revenue and Growth Rate (2014-2019)
10 Global Degarelix Market Segment by Type
10.1 Global Degarelix Revenue and Market Share by Type (2014-2019)
10.2 Global Degarelix Market Forecast by Type (2019-2024)
10.3 120 mg per vial Revenue Growth Rate (2014-2024)
10.4 80 mg per vial Revenue Growth Rate (2014-2024)
11 Global Degarelix Market Segment by Application
11.1 Global Degarelix Revenue Market Share by Application (2014-2019)
11.2 Degarelix Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Drug store Revenue Growth (2014-2019)
12 Global Degarelix Market Size Forecast (2019-2024)
12.1 Global Degarelix Market Size Forecast (2019-2024)
12.2 Global Degarelix Market Forecast by Regions (2019-2024)
12.3 North America Degarelix Revenue Market Forecast (2019-2024)
12.4 Europe Degarelix Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Degarelix Revenue Market Forecast (2019-2024)
12.6 South America Degarelix Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Degarelix Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Degarelix Picture
Table Product Specifications of Degarelix
Table Global Degarelix and Revenue (Million USD) Market Split by Product Type
Figure Global Degarelix Revenue Market Share by Types in 2018
Figure 120 mg per vial Picture
Figure 80 mg per vial Picture
Table Global Degarelix Revenue (Million USD) by Application (2014-2024)
Figure Degarelix Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Drug store Picture
Table Global Market Degarelix Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Degarelix Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Degarelix Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Degarelix Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Degarelix Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Degarelix Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Degarelix Revenue (Million USD) and Growth Rate (2014-2024)
Table Ferring Basic Information, Manufacturing Base and Competitors
Table Ferring Degarelix Type and Applications
Table Ferring Degarelix Revenue, Gross Margin and Market Share (2017-2018)
Table Global Degarelix Revenue (Million USD) by Players (2014-2019)
Table Global Degarelix Revenue Share by Players (2014-2019)
Figure Global Degarelix Revenue Share by Players in 2017
Figure Global Degarelix Revenue Share by Players in 2018
Figure Global Top 5 Players Degarelix Revenue Market Share in 2018
Figure Global Top 10 Players Degarelix Revenue Market Share in 2018
Figure Global Degarelix Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Degarelix Revenue (Million USD) by Regions (2014-2019)
Table Global Degarelix Revenue Market Share by Regions (2014-2019)
Figure Global Degarelix Revenue Market Share by Regions (2014-2019)
Figure Global Degarelix Revenue Market Share by Regions in 2018
Figure North America Degarelix Revenue and Growth Rate (2014-2019)
Figure Europe Degarelix Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Degarelix Revenue and Growth Rate (2014-2019)
Figure South America Degarelix Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Degarelix Revenue and Growth Rate (2014-2019)
Table North America Degarelix Revenue by Countries (2014-2019)
Table North America Degarelix Revenue Market Share by Countries (2014-2019)
Figure North America Degarelix Revenue Market Share by Countries (2014-2019)
Figure North America Degarelix Revenue Market Share by Countries in 2018
Figure USA Degarelix Revenue and Growth Rate (2014-2019)
Figure Canada Degarelix Revenue and Growth Rate (2014-2019)
Figure Mexico Degarelix Revenue and Growth Rate (2014-2019)
Table Europe Degarelix Revenue (Million USD) by Countries (2014-2019)
Figure Europe Degarelix Revenue Market Share by Countries (2014-2019)
Figure Europe Degarelix Revenue Market Share by Countries in 2018
Figure Germany Degarelix Revenue and Growth Rate (2014-2019)
Figure UK Degarelix Revenue and Growth Rate (2014-2019)
Figure France Degarelix Revenue and Growth Rate (2014-2019)
Figure Russia Degarelix Revenue and Growth Rate (2014-2019)
Figure Italy Degarelix Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Degarelix Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Degarelix Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Degarelix Revenue Market Share by Countries in 2018
Figure China Degarelix Revenue and Growth Rate (2014-2019)
Figure Japan Degarelix Revenue and Growth Rate (2014-2019)
Figure Korea Degarelix Revenue and Growth Rate (2014-2019)
Figure India Degarelix Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Degarelix Revenue and Growth Rate (2014-2019)
Table South America Degarelix Revenue by Countries (2014-2019)
Table South America Degarelix Revenue Market Share by Countries (2014-2019)
Figure South America Degarelix Revenue Market Share by Countries (2014-2019)
Figure South America Degarelix Revenue Market Share by Countries in 2018
Figure Brazil Degarelix Revenue and Growth Rate (2014-2019)
Figure Argentina Degarelix Revenue and Growth Rate (2014-2019)
Figure Colombia Degarelix Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Degarelix Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Degarelix Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Degarelix Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Degarelix Revenue Market Share by Countries in 2018
Figure Saudi Arabia Degarelix Revenue and Growth Rate (2014-2019)
Figure UAE Degarelix Revenue and Growth Rate (2014-2019)
Figure Egypt Degarelix Revenue and Growth Rate (2014-2019)
Figure Nigeria Degarelix Revenue and Growth Rate (2014-2019)
Figure South Africa Degarelix Revenue and Growth Rate (2014-2019)
Table Global Degarelix Revenue (Million USD) by Type (2014-2019)
Table Global Degarelix Revenue Share by Type (2014-2019)
Figure Global Degarelix Revenue Share by Type (2014-2019)
Figure Global Degarelix Revenue Share by Type in 2019
Table Global Degarelix Revenue Forecast by Type (2019-2024)
Figure Global Degarelix Market Share Forecast by Type (2019-2024)
Figure Global 120 mg per vial Revenue Growth Rate (2014-2019)
Figure Global 80 mg per vial Revenue Growth Rate (2014-2019)
Table Global Degarelix Revenue by Application (2014-2019)
Table Global Degarelix Revenue Share by Application (2014-2019)
Figure Global Degarelix Revenue Share by Application (2014-2019)
Figure Global Degarelix Revenue Share by Application in 2019
Table Global Degarelix Revenue Forecast by Application (2019-2024)
Figure Global Degarelix Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Drug store Revenue Growth Rate (2014-2019)
Figure Global Degarelix Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Degarelix Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Degarelix Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Degarelix Revenue Market Forecast (2019-2024)
Figure Europe Degarelix Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Degarelix Revenue Market Forecast (2019-2024)
Figure South America Degarelix Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Degarelix Revenue Market Forecast (2019-2024)
世界のクローズドドラッグトランスファーシステム市場予測（～2024年） Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment …- 世界の薬物中毒治療市場予測（～2024年） Drug addiction is a complex neurobiological disease that requires integrated treatment of the mind, body, and spirit. It is considered a brain disease because drugs change the brain — they change its structure and how it works. Without treatment, these brain changes can be long-lasting. Addiction is…
- 世界のセルトリズマブペゴル市場予測（～2024年） Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Scope of the Report: The global Certolizumab pegol market is valued at xx million USD in 2018 and is expected to reach xx…
- 世界の薬物乱用治療市場予測（～2024年） Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for t…
- 世界のクレビジピン市場予測（～2024年） Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable. Scope of the Report: The global Clevidipine market is valued at xx million USD in 2018 and is expected to reach xx mi…